BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Xiao L, Sun L, Zhao K, Pan YS. Crohn’s disease with infliximab treatment complicated by rapidly progressing colorectal cancer: A case report. World J Gastrointest Oncol 2021; 13(4): 305-311 [PMID: 33889281 DOI: 10.4251/wjgo.v13.i4.305]
URL: https://www.wjgnet.com/1007-9327/full/v13/i4/305.htm
Number Citing Articles
1
InfliximabReactions Weekly 2021; 1867(1): 210 doi: 10.1007/s40278-021-00270-2
2
Shruthi Karthikeyan, Jeanne Shen, Kian Keyashian, John Gubatan. Small bowel adenocarcinoma in neoterminal ileum in setting of stricturing Crohn’s disease: A case report and review of literature World Journal of Clinical Cases 2023; 11(9): 2021-2028 doi: 10.12998/wjcc.v11.i9.2021
3
Ronaldo Teixeira da Silva Júnior, Jonathan Santos Apolonio, Jessica Oliveira de Souza Nascimento, Bruna Teixeira da Costa, Luciano Hasimoto Malheiro, Marcel Silva Luz, Lorena Sousa de Carvalho, Cleiton da Silva Santos, Fabrício Freire de Melo. Crohn's disease and clinical management today: How it does?World Journal of Methodology 2023; 13(5): 399-413 doi: 10.5662/wjm.v13.i5.399
4
Yoshiki Morihisa, Shunji Urai, Hiroyoshi Iwagami, Masayuki Shimoyama, Shinya Ogino, Tomoko Terashita, Hiroki Morimura, Takuji Akamatsu, Yoshito Uenoyama, Yukitaka Yamashita. Primary Retroperitoneal Mucinous Cystadenocarcinoma during Long-term Administration of Infliximab for the Treatment of Crohn's DiseaseInternal Medicine 2023; 62(24): 3619 doi: 10.2169/internalmedicine.1593-23